Every day, Pfizer colleagues work to provide improved health outcomes by supporting preventions, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as a World leading biopharmaceutical company, we collaborate with healthcare providers, governments and local communities to support and expand access to reliable and affordable health care for the community. 

Pfizer Anti-Infectives has undertaken to prioritise research, education and drug development initiatives designed to help address the critical need for novel antimicrobial medicines, a better understanding of bacterial antibiotic resistance and projects to enhance antimicrobial stewardship. Please visit us at www.pfizer.com.au

The Institute for Health Transformation, Deakin University, is addressing the 21st century’s most complex and compelling health challenges through excellence in collaborative research that transforms the design and delivery of prevention and care across health systems. We are committed to building knowledge and skills in situational awareness and risk assessment for existing and emerging diseases and evaluating the effectiveness of control measures. Our infectious disease epidemiological and biostatistical research generates, communicates and translates high-quality evidence into public health practice and disease prevention and control strategies to improve public policy and population health.